MIRM — Mirum Pharmaceuticals Inc

In 2026 Q2, 7 of the 140 tracked hedge funds reported a position in Mirum Pharmaceuticals Inc (MIRM), worth $252.69M combined. Over the quarter 4 opened or added, 3 trimmed or exited.

Hedge fund holders, 2026 Q2

FundValuePortfolio %Change
Polar Capital$98.99M0.28%+198.3%
Emerald$54.82M1.30%+17.9%
Renaissance$51.77M0.07%-24%
Emerald Mutual$33.88M1.20%+15.6%
Essex$12.37M1.60%-2.5%
Persistent$515.58K0.16%+23%
Kohlberg$348.04K0.00%-61.5%

All stocks · Quarterly Trends · Hedge Fund Tracker

Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.